Coronary artery spasm during exercise: treatment with verapamil.
- 30 June 1981
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 64 (1) , 68-75
- https://doi.org/10.1161/01.cir.64.1.68
Abstract
Six patients who had documented coronary spasm and no coronary artery with organic obstruction greater than 50% developed angina and ST-segment elevation on exercise testing. Oral verapamil, 160-480 mg/day, prevented exercise-induced ischemia in all patients and increased maximal work capacity from 611+/- 250 kpm to 808 +/- 160 kpm (p less than 0.02). In two patients, a relationship between the prevention of exercise-provoked ischemia and the plasma concentration of verapamil was demonstrated, and in one of these, the relationship had a diurnal pattern. Patients with variant angina may develop coronary spasm on effort and often respond to verapamil.This publication has 11 references indexed in Scilit:
- Coronary Artery Spasm: Use of Ergonovine in Diagnosis *Australian and New Zealand Journal of Medicine, 1980
- Serial Exercise Thallium Myocardial Perfusion Scanning and Exercise Electrocardiography in the Diagnosis of Coronary Artery Disease*Australian and New Zealand Journal of Medicine, 1979
- Coronary arterial spasm as a cause of exercise-induced ST-segment elevation in patients with variant angina.Circulation, 1979
- Circadian variation of exercise capacity in patients with Prinzmetal's variant angina: role of exercise-induced coronary arterial spasm.Circulation, 1979
- Coronary artery spasm during exercise in patients with variant angina.Circulation, 1979
- Rapid high-pressure liquid chromatographic analysis of verapamil in blood and plasmaJournal of Chromatography A, 1979
- Similarities of ergonovine-induced and spontaneous attacks of variant angina.Circulation, 1979
- Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations.Circulation, 1978
- Physiological disposition of verapamil in manCardiovascular Research, 1976